Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

Purpose: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). Methods and Materials: We queried a consortium database for patients with IBD receiving SBRT for prostate cancer between 2006 and 2012. Identified patients...

Full description

Bibliographic Details
Main Authors: Jesus E. Juarez, MD, Tahmineh Romero, MS, Constantine A. Mantz, MD, Abigail Pepin, MD, Nima Aghdam, MD, Simeng Suy, PhD, Michael L. Steinberg, MD, Rebecca G. Levin-Epstein, MD, Nicholas G. Nickols, MD, PhD, Irving D. Kaplan, MD, Robert M. Meier, MD, Huong T. Pham, MD, Patrick W. Linson, MD, Robert L. Hong, MD, Mark K. Buyyounouski, MD, Hilary P. Bagshaw, MD, Donald B. Fuller, MD, Alan J. Katz, MD, Andrew Loblaw, MD, Sean P. Collins, MD, PhD, Amar U. Kishan, MD
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109421001172

Internet

http://www.sciencedirect.com/science/article/pii/S2452109421001172

Similar Items